Skip to main content

Advertisement

SpringerLink
Log in

Relationship Between Hematoma Expansion Induced by Hypertension and Hyperglycemia and Blood–brain Barrier Disruption in Mice and Its Possible Mechanism: Role of Aquaporin-4 and Connexin43

  • Original Article
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

We aimed to select an optimized hematoma expansion (HE) model and investigate the possible mechanism of blood–brain barrier (BBB) damage in mice. The results showed that HE occurred in the group with hypertension combined with hyperglycemia (HH-HE) from 3 to 72 h after intracerebral hemorrhage; this was accompanied by neurological deficits and hardly influenced the survival rate. The receiver operating characteristic curve suggested the criterion for this model was hematoma volume expansion ≥ 45.0%. Meanwhile, HH-HE aggravated BBB disruption. A protector of the BBB reduced HH-HE, while a BBB disruptor induced a further HH-HE. Aquaporin-4 (AQP4) knock-out led to larger hematoma volume and more severe BBB disruption. Furthermore, hematoma volume and BBB disruption were reduced by multiple connexin43 (Cx43) inhibitors in the wild-type group but not in the AQP4 knock-out group. In conclusion, the optimized HE model is induced by hypertension and hyperglycemia with the criterion of hematoma volume expanding ≥ 45.0%. HH-HE leads to BBB disruption, which is dependent on AQP4 and Cx43.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010, 9: 167–176.

    Article  PubMed  Google Scholar 

  2. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012, 11: 307–314.

    Article  PubMed  Google Scholar 

  3. Chu H, Huang C, Dong J, Yang X, Xiang J, Mao Y, et al. Minimal computed tomography attenuation value within the hematoma is associated with hematoma expansion and poor outcome in intracerebral hemorrhage patients. Neurocrit Care 2019, 31: 455–456.

    Article  CAS  PubMed  Google Scholar 

  4. Chu H, Huang C, Dong J, Yang X, Xiang J, Dong Q, et al. Lactate dehydrogenase predicts early hematoma expansion and poor outcomes in intracerebral hemorrhage patients. Transl Stroke Res 2019, 10: 620–629.

    Article  CAS  PubMed  Google Scholar 

  5. Schlunk F, Van Cott EM, Hayakawa K, Pfeilschifter W, Lo EH, Foerch C. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke 2012, 43: 246–249.

    Article  CAS  PubMed  Google Scholar 

  6. Na SY, Mracsko E, van Ryn J, Veltkamp R. Idarucizumab improves outcome in murine brain hemorrhage related to dabigatran. Ann Neurol 2015, 78: 137–141.

    Article  CAS  PubMed  Google Scholar 

  7. Zhou W, Zorn M, Nawroth P, Bütehorn U, Perzborn E, Heitmeier S, et al. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban. Stroke 2013, 44: 771–778.

    Article  CAS  PubMed  Google Scholar 

  8. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5.

    Article  CAS  PubMed  Google Scholar 

  9. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006, 66: 1175–1181.

    Article  CAS  PubMed  Google Scholar 

  10. Morotti A, Charidimou A, Phuah CL, Jessel MJ, Schwab K, Ayres AM, et al. Association between serum calcium level and extent of bleeding in patients with intracerebral hemorrhage. JAMA Neurol 2016, 73: 1285–1290.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Dávalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005, 36: 86–91.

    Article  PubMed  Google Scholar 

  12. Zheng Y, Hu Q, Manaenko A, Zhang Y, Peng Y, Xu L, et al. 17β-Estradiol attenuates hematoma expansion through estrogen receptor α/silent information regulator 1/nuclear factor-kappa b pathway in hyperglycemic intracerebral hemorrhage mice. Stroke 2015, 46: 485–491.

    Article  CAS  PubMed  Google Scholar 

  13. Chu H, Huang C, Ding H, Gao Z, Dong J, Tang Y, et al. Aquaproin-4 and cerebrovascular diseases. Int J Mol Sci 2016, 17: 1249.

    Article  PubMed Central  CAS  Google Scholar 

  14. Verkman AS. Knock-out models reveal new aquaporin functions. Handb Exp Pharmacol 2009, 190: 359–381.

    Article  CAS  Google Scholar 

  15. Chu H, Tang Y, Dong Q. Protection of vascular endothelial growth factor to brain edema following intracerebral hemorrhage and its involved mechanisms: effect of aquaporin-4. PLoS One 2013, 8: e66051.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Chu H, Ding H, Tang Y, Dong Q. Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4. Lab Invest 2014, 94: 1042–1053.

    Article  CAS  PubMed  Google Scholar 

  17. Volbers B, Giede-Jeppe A, Gerner ST, Sembill JA, Kuramatsu JB, Lang S, et al. Peak perihemorrhagic edema correlates with functional outcome in intracerebral hemorrhage. Neurology 2018, 90: e1005–e1012.

    Article  PubMed  Google Scholar 

  18. Yang X, Chu H, Tang Y, Dong Q. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro. Neuroscience 2016, 329: 54–65.

    Article  CAS  PubMed  Google Scholar 

  19. Chu H, Huang C, Gao Z, Dong J, Tang Y, Dong Q. Reduction of ischemic brain edema by combined use of Paeoniflorin and Astragaloside IV via down-regulating connexin 43. Phytother Res 2017, 31: 1410–1418.

    Article  CAS  PubMed  Google Scholar 

  20. Meissner A, Minnerup J, Soria G, Planas AM. Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension. J Neurochem 2017, 140: 509–521.

    Article  CAS  PubMed  Google Scholar 

  21. Grossetete M, Rosenberg GA. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse. J Cereb Blood Flow Metab 2008, 28: 752–763.

    Article  CAS  PubMed  Google Scholar 

  22. Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, et al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation 2015, 12: 223.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Zhou Z, Wei X, Xiang J, Gao J, Wang L, You J, et al. Protection of erythropoietin against ischemic neurovascular unit injuries through the effects of connexin43. Biochem Biophys Res Commun 2015, 458: 656–662.

    Article  CAS  PubMed  Google Scholar 

  24. Mracsko E, Javidi E, Na SY, Kahn A, Liesz A, Veltkamp R. Leukocyte invasion of the brain after experimental intracerebral hemorrhage in mice. Stroke 2014, 45: 2107–2114.

    Article  PubMed  Google Scholar 

  25. Zhou W, Schwarting S, Illanes S, Illanes S, Liesz A, Middelhoff M, et al. Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran. Stroke 2011, 42: 3594–3599.

    Article  PubMed  Google Scholar 

  26. Liew HK, Pang CY, Hsu CW, Hsu CW, Wang MJ, Li TY, et al. Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats. J Neuroinflammation 2012, 9: 13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Belayev L, Saul I, Curbelo K, Busto R, Belayev A, Zhang Y, et al. Experimental intracerebral hemorrhage in the mouse histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 2003, 34: 2221–2227.

    Article  PubMed  Google Scholar 

  28. Chu H, Xiang J, Wu P, Su J, Ding H, Tang Y, et al. The role of aquaporin 4 in apoptosis after intracerebral hemorrhage. J Neuroinflammation 2014, 11: 184.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Chu H, Tang Y, Dong Q. Protection of granulocyte-colony stimulating factor to hemorrhagic brain injuries and its involved mechanisms: effects of vascular endothelial growth factor and aquaporin-4. Neuroscience 2014, 260: 59–72.

    Article  CAS  PubMed  Google Scholar 

  30. Huang C, Dai C, Gong K, Zuo H, Chu H. Apelin-13 protects neurovascular unit against ischemic injuries through the effects of vascular endothelial growth factor. Neuropeptides 2016, 60: 67–74.

    Article  CAS  PubMed  Google Scholar 

  31. Chu H, Yang X, Huang C, Gao Z, Tang Y, Dong Q. Apelin-13 Protects against ischemic blood-brain barrier damage through the effects of aquaporin-4. Cerebrovasc Dis 2017, 44: 10–25.

    Article  CAS  PubMed  Google Scholar 

  32. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 2016, 375: 1033–1043.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Liu J, Gao BB, Clermont AC, Blair P, Chilcote TJ, Sinha S, et al. Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat Med 2011, 17: 206–210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke 2010, 5: 110–116.

    Article  CAS  PubMed  Google Scholar 

  35. Dong J, Yang X, Xiang J, Dong Q, Tang Y, Chu H. Hypodensities detected at 1.5–3 h after intracerebral hemorrhage better predicts secondary neurological deterioration. J Neurol Sci 2019, 396: 219–224

    Article  PubMed  Google Scholar 

  36. Hu HM, Li B, Wang XD, Guo YS, Hui H, Zhang HP, et al. Fluoxetine is neuroprotective in early brain injury via its anti-inflammatory and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model. Neurosci Bull 2018, 34:951–962.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Schlunk F, Greenberg SM. The pathophysiology of intracerebral hemorrhage formation and expansion. Transl Stroke Res 2015, 6:257–263.

    Article  CAS  PubMed  Google Scholar 

  38. Boulouis G, Dumas A, Betensky RA, Brouwers HB, Fotiadis P, Vashkevich A, et al. Anatomic pattern of intracerebral hemorrhage expansion: relation to CT angiography spot sign and hematoma center. Stroke 2014, 45:1154–1156.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Freeze WM, Jacobs HIL, Schreuder FHBM, van Oostenbrugge RJ, Backes WH, Verhey FR, et al. Blood-brain barrier dysfunction in small vessel disease related intracerebral hemorrhage. Front Neurol 2018, 9: 926.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Howe MD, Zhu L, Sansing LH, Gonzales NR, McCullough LD, Edwards NJ. Serum markers of blood-brain barrier remodeling and fibrosis as predictors of etiology and clinicoradiologic outcome in intracerebral hemorrhage. Front Neurol 2018, 9: 746.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Urrutia A, Rubio-Araiz A, Gutierrez-Lopez MD, ElAli A, Hermann DM, O’Shea E, et al. A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine. Neurobiol Dis 2013, 50: 49–58.

    Article  CAS  PubMed  Google Scholar 

  42. Yu Y, Xue BJ, Zhang ZH, Wei SG, Beltz TG, Guo F, et al. Early interference with p44/42 mitogen-activated protein kinase signaling in hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension. Hypertension 2013, 61: 842–849.

    Article  CAS  PubMed  Google Scholar 

  43. Farrokhnia N, Roos MW, Terént A, Lennmyr F. Differential early mitogen-activated protein kinase activation in hyperglycemic ischemic brain injury in the rat. Eur J Clin Invest 2005, 35: 457–463.

    Article  CAS  PubMed  Google Scholar 

  44. Auguste KI, Jin S, Uchida K, Yan D, Manley GT, Papadopoulos MC, et al. Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J 2007, 21: 108–116.

    Article  CAS  PubMed  Google Scholar 

  45. Nico B, Frigeri A, Nicchia GP, Quondamatteo F, Herken R, Errede M, et al. Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J Cell Sci 2001, 114: 1297–1307.

    Article  CAS  PubMed  Google Scholar 

  46. Kimura A, Hsu M, Seldin M, Verkman AS, Scharfman HE, Binder DK. Protective role of aquaporin-4 water channels after contusion spinal cord injury. Ann Neurol 2010, 67: 794–801.

    PubMed  Google Scholar 

  47. Uzu M, Sin WC, Shimizu A, Sato H. Conflicting roles of connexin43 in tumor invasion and growth in the central nervous system. Int J Mol Sci 2018, 11: 19.

    Google Scholar 

  48. Chew SSL, Johnson CS, Green CR, Danesh-Meyer HV. Role of connexin43 in central nervous system injury. Exp Neurol 2010, 225: 250–261.

    Article  CAS  PubMed  Google Scholar 

  49. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 2009, 419: 261–272.

    Article  CAS  PubMed  Google Scholar 

  50. Ezan P, André P, Cisternino S, Saubaméa B, Boulay AC, Doutremer S, et al. Deletion of astroglial connexins weakens the blood-brain barrier. J Cereb Blood Flow Metab 2012, 32: 1457–1467.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Lima F, Niger C, Hebert C, Stains JP. Connexin43 potentiates osteoblast responsiveness to fibroblast growth factor 2 via a protein kinase C-delta/runx2-dependent mechanism. Mol Biol Cell 2009, 20: 2697–2708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. McCoy ES, Haas BR, Sontheimer H. Water permeability through aquaporin-4 is regulated by protein kinase C and becomes rate-limiting for glioma invasion. Neuroscience 2010, 168: 971–981.

    Article  CAS  PubMed  Google Scholar 

  53. Niger C, Buo AM, Hebert C, Duggan BT, Williams MS, Stains JP. ERK acts in parallel to PKC delta to mediate the connexin43-dependent potentiation of Runx2 activity by FGF2 in MC3T3 osteoblasts. Am J Physiol Cell Physiol 2012, 302: C1035–C1044.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (81500998 and 81901102), the Science and Technology Commission of Shanghai Municipality (16140903200), Shanghai Sixth People’s Hospital Medical Group (2017LY01), the Research Fund of Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine (TRYJ201701), and the Research Fund of North Huashan Hospital, Fudan University (HSBY2019004).

Author information

Author notes

  1. Heling Chu, Zidan Gao and Chuyi Huang have contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, 200040, China

    Heling Chu, Jing Dong, Yuping Tang & Qiang Dong

  2. Department of Neurology, North Huashan Hospital, Fudan University, Shanghai, 201907, China

    Heling Chu

  3. Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China

    Zidan Gao

  4. Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China

    Chuyi Huang

Authors
  1. Heling Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zidan Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chuyi Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuping Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qiang Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuping Tang or Qiang Dong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 299 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chu, H., Gao, Z., Huang, C. et al. Relationship Between Hematoma Expansion Induced by Hypertension and Hyperglycemia and Blood–brain Barrier Disruption in Mice and Its Possible Mechanism: Role of Aquaporin-4 and Connexin43. Neurosci. Bull. 36, 1369–1380 (2020). https://doi.org/10.1007/s12264-020-00540-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-020-00540-4

Keywords

Search

Navigation